Jpmorgan Chase & Co - Mar 31, 2025 SCHEDULE 13G Report for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares
Shares outstanding: 6.82B shares
Disclosed Ownership: 430M shares
Ownership: 6.3%
Form type: SCHEDULE 13G
Date filed: 5/2/2025, 09:59 AM
Date of event: Mar 31, 2025
Next filing: May 5, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	6.3%	430M	430M	0	Rachel Tsvaygoft	Vice President